Your browser doesn't support javascript.
loading
Genetic and phenotypic dissection of 1q43q44 microdeletion syndrome and neurodevelopmental phenotypes associated with mutations in ZBTB18 and HNRNPU.
Depienne, Christel; Nava, Caroline; Keren, Boris; Heide, Solveig; Rastetter, Agnès; Passemard, Sandrine; Chantot-Bastaraud, Sandra; Moutard, Marie-Laure; Agrawal, Pankaj B; VanNoy, Grace; Stoler, Joan M; Amor, David J; Billette de Villemeur, Thierry; Doummar, Diane; Alby, Caroline; Cormier-Daire, Valérie; Garel, Catherine; Marzin, Pauline; Scheidecker, Sophie; de Saint-Martin, Anne; Hirsch, Edouard; Korff, Christian; Bottani, Armand; Faivre, Laurence; Verloes, Alain; Orzechowski, Christine; Burglen, Lydie; Leheup, Bruno; Roume, Joelle; Andrieux, Joris; Sheth, Frenny; Datar, Chaitanya; Parker, Michael J; Pasquier, Laurent; Odent, Sylvie; Naudion, Sophie; Delrue, Marie-Ange; Le Caignec, Cédric; Vincent, Marie; Isidor, Bertrand; Renaldo, Florence; Stewart, Fiona; Toutain, Annick; Koehler, Udo; Häckl, Birgit; von Stülpnagel, Celina; Kluger, Gerhard; Møller, Rikke S; Pal, Deb; Jonson, Tord.
Afiliación
  • Depienne C; IGBMC, CNRS UMR 7104/INSERM U964/Université de Strasbourg, 67400, Illkirch, France. depiennc@igbmc.fr.
  • Nava C; Laboratoires de Génétique, Institut de Génétique médicale d'Alsace, Hôpitaux Universitaires de Strasbourg, 67000, Strasbourg, France. depiennc@igbmc.fr.
  • Keren B; INSERM, U 1127, CNRS UMR 7225, Institut du Cerveau et de la Moelle épinière, ICM, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, 75013, Paris, France. depiennc@igbmc.fr.
  • Heide S; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique, 75013, Paris, France. depiennc@igbmc.fr.
  • Rastetter A; EuroEPINOMICS RES consortium, . depiennc@igbmc.fr.
  • Passemard S; INSERM, U 1127, CNRS UMR 7225, Institut du Cerveau et de la Moelle épinière, ICM, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, 75013, Paris, France.
  • Chantot-Bastaraud S; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique, 75013, Paris, France.
  • Moutard ML; EuroEPINOMICS RES consortium.
  • Agrawal PB; INSERM, U 1127, CNRS UMR 7225, Institut du Cerveau et de la Moelle épinière, ICM, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, 75013, Paris, France.
  • VanNoy G; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique, 75013, Paris, France.
  • Stoler JM; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique, 75013, Paris, France.
  • Amor DJ; Groupe de Recherche Clinique (GRC) "déficience intellectuelle et autisme" UPMC, Groupe Hospitalier Pitié-Salpêtrière, 75013, Paris, France.
  • Billette de Villemeur T; INSERM, U 1127, CNRS UMR 7225, Institut du Cerveau et de la Moelle épinière, ICM, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, 75013, Paris, France.
  • Doummar D; AP-HP, Department of Child Neurology, Hôpital Robert Debré, Paris, France.
  • Alby C; AP-HP, Department of Genetics, Hôpital Robert Debré, Paris, France.
  • Cormier-Daire V; INSERM UMR U1141, Hôpital Robert Debré, Université Paris-Diderot, Sorbonne Paris Cité, Paris, France.
  • Garel C; AP-HP, Département de Génétique Médicale, Unité fonctionnelle de Génétique Chromosomique, CHU Paris Est, Hôpital d'Enfants Armand-Trousseau, 75571, Paris, France.
  • Marzin P; AP-HP, Service de Neuropédiatrie, Hôpital Trousseau, 75012, Paris, France.
  • Scheidecker S; UPMC, GRC ConCer-LD, Sorbonne Université, Paris, France.
  • de Saint-Martin A; Centre de Référence des Maladies Neurogénétiques de l'Enfant et de l'Adolescent, Paris, France.
  • Hirsch E; Divisions of Genetics and Genomics and Newborn Medicine, Manton Center for Orphan Disease Research, Boston Children's Hospital and Harvard Medical School, Boston, MA, 02115, USA.
  • Korff C; Divisions of Genetics and Genomics and Newborn Medicine, Manton Center for Orphan Disease Research, Boston Children's Hospital and Harvard Medical School, Boston, MA, 02115, USA.
  • Bottani A; Divisions of Genetics and Genomics and Newborn Medicine, Manton Center for Orphan Disease Research, Boston Children's Hospital and Harvard Medical School, Boston, MA, 02115, USA.
  • Faivre L; Murdoch Childrens Research Institute, Royal Children's Hospital, Parkville, VIC, 3052, Australia.
  • Verloes A; Department of Paediatrics, University of Melbourne, Parkville, VIC, 3052, Australia.
  • Orzechowski C; INSERM UMR U1141, Hôpital Robert Debré, Université Paris-Diderot, Sorbonne Paris Cité, Paris, France.
  • Burglen L; AP-HP, Service de Neuropédiatrie, Hôpital Trousseau, 75012, Paris, France.
  • Leheup B; UPMC, GRC ConCer-LD, Sorbonne Université, Paris, France.
  • Roume J; Centre de Référence "déficiences intellectuelles de causes rares", Paris, France.
  • Andrieux J; AP-HP, Service de Neuropédiatrie, Hôpital Trousseau, 75012, Paris, France.
  • Sheth F; Centre de Référence des Maladies Neurogénétiques de l'Enfant et de l'Adolescent, Paris, France.
  • Datar C; INSERM U1163, Laboratory of Embryology and Genetics of Congenital Malformations, Sorbonne Paris Cité and Imagine Institute, Paris Descartes University, 75015, Paris, France.
  • Parker MJ; AP-HP, Département de Génétique, Hôpital Necker-Enfants Malades, 75015, Paris, France.
  • Pasquier L; INSERM U1163, Laboratory of Molecular and Physiopathological bases of osteochondrodysplasia, Sorbonne Paris Cité and Imagine Institute, Paris Descartes University, 75015, Paris, France.
  • Odent S; AP-HP, Département de Génétique, Hôpital Necker-Enfants Malades, 75015, Paris, France.
  • Naudion S; AP-HP, GHUEP, Service de Radiologie, Hôpital Armand-Trousseau, 75012, Paris, France.
  • Delrue MA; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique, 75013, Paris, France.
  • Le Caignec C; Laboratoires de Génétique, Institut de Génétique médicale d'Alsace, Hôpitaux Universitaires de Strasbourg, 67000, Strasbourg, France.
  • Vincent M; IGBMC, CNRS UMR 7104/INSERM U964/Université de Strasbourg, 67400, Illkirch, France.
  • Isidor B; Pediatric Neurology Department, Hautepierre Hospital, Strasbourg University Hospital, Strasbourg, France.
  • Renaldo F; IGBMC, CNRS UMR 7104/INSERM U964/Université de Strasbourg, 67400, Illkirch, France.
  • Stewart F; Medical and Surgical Epilepsy Unit, Hautepierre Hospital, Strasbourg University Hospital, Strasbourg, France.
  • Toutain A; Département de l'Enfant et de l'Adolescent, Neuropédiatrie, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Koehler U; Service de Médecine génétique, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Häckl B; Equipe d'Accueil 4271, Génétique des Anomalies du Développement, Université de Bourgogne, 21079, Dijon, France.
  • von Stülpnagel C; Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Interrégion Est, Centre Hospitalier Universitaire Dijon, 21079, Dijon, France.
  • Kluger G; AP-HP, Department of Genetics, Hôpital Robert Debré, Paris, France.
  • Møller RS; Service de Pédiatrie, Hôpital Saint-Camille Bry-sur-Marne, Le Chesnay, France.
  • Pal D; INSERM UMR U1141, Hôpital Robert Debré, Université Paris-Diderot, Sorbonne Paris Cité, Paris, France.
  • Jonson T; AP-HP, Service de Génétique, Hôpital Trousseau, 75012, Paris, France.
Hum Genet ; 136(4): 463-479, 2017 04.
Article en En | MEDLINE | ID: mdl-28283832
Subtelomeric 1q43q44 microdeletions cause a syndrome associating intellectual disability, microcephaly, seizures and anomalies of the corpus callosum. Despite several previous studies assessing genotype-phenotype correlations, the contribution of genes located in this region to the specific features of this syndrome remains uncertain. Among those, three genes, AKT3, HNRNPU and ZBTB18 are highly expressed in the brain and point mutations in these genes have been recently identified in children with neurodevelopmental phenotypes. In this study, we report the clinical and molecular data from 17 patients with 1q43q44 microdeletions, four with ZBTB18 mutations and seven with HNRNPU mutations, and review additional data from 37 previously published patients with 1q43q44 microdeletions. We compare clinical data of patients with 1q43q44 microdeletions with those of patients with point mutations in HNRNPU and ZBTB18 to assess the contribution of each gene as well as the possibility of epistasis between genes. Our study demonstrates that AKT3 haploinsufficiency is the main driver for microcephaly, whereas HNRNPU alteration mostly drives epilepsy and determines the degree of intellectual disability. ZBTB18 deletions or mutations are associated with variable corpus callosum anomalies with an incomplete penetrance. ZBTB18 may also contribute to microcephaly and HNRNPU to thin corpus callosum, but with a lower penetrance. Co-deletion of contiguous genes has additive effects. Our results confirm and refine the complex genotype-phenotype correlations existing in the 1qter microdeletion syndrome and define more precisely the neurodevelopmental phenotypes associated with genetic alterations of AKT3, ZBTB18 and HNRNPU in humans.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fenotipo / Proteínas Represoras / Cromosomas Humanos Par 1 / Deleción Cromosómica / Ribonucleoproteínas Nucleares Heterogéneas / Trastornos del Neurodesarrollo / Mutación Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Hum Genet Año: 2017 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fenotipo / Proteínas Represoras / Cromosomas Humanos Par 1 / Deleción Cromosómica / Ribonucleoproteínas Nucleares Heterogéneas / Trastornos del Neurodesarrollo / Mutación Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Hum Genet Año: 2017 Tipo del documento: Article País de afiliación: Francia